Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres

Trastuzumab - Deruxtecan (T-DXd) With Lyudmila Bazhenova And Julien Mazieres

On the heels of accelerated approval by the US FDA, Dr. Stephen Liu discusses trastuzumab-deruxtecan (T-DXd) with medical oncologists and clinical investigators, Dr. Lyudmila Bazhenova, from the University of California, San Diego, and Dr. Julian Mazieres, from Toulouse University Hospital. T-DXd is an antibody-drug conjugate now approved for the treatment of HER2-mutant NSCLC, and in this episode, its design, efficacy, and safety are reviewed.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(392)

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped ...

23 Jun 45min

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -...

12 Jun 39min

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy adva...

9 Jun 40min

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted ther...

5 Jun 45min

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

Patients, AI, and Lung Cancer: Finding Clarity in the Noise

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the conte...

19 Mai 46min

LCC in Italian: Resectable EGFR-mutant NSCLC

LCC in Italian: Resectable EGFR-mutant NSCLC

As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuse...

8 Mai 49min

AACR 2026 Highlights: KRAS Updates

AACR 2026 Highlights: KRAS Updates

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David...

5 Mai 46min

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussion with Dr. José Corona-Cruz and Dr. Diego Carrillo o...

24 Apr 48min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
forskningno
liberal-halvtime
rekommandert
sinnsyn
villmarksliv
dekodet-2
tomprat-med-gunnar-tjomlid
smart-forklart
rss-nysgjerrige-norge
fjellsportpodden
rss-kunstig-intelligens-med-elisabeth-maren-og-morten
nevropodden
rss-rekommandert
rss-paradigmepodden
rss-overskuddsliv
abels-tarn
rss-bondevennen